Boenning & Scattergood’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $7.01M | Sell |
135,405
-3,405
| -2% | -$176K | 1.13% | 9 |
|
|
2022
Q3 | $6.07M | Buy |
138,810
+9,565
| +7% | +$419K | 1.24% | 11 |
|
|
2022
Q2 | $6.78M | Sell |
129,245
-6,160
| -5% | -$323K | 1.28% | 9 |
|
|
2022
Q1 | $7.01M | Buy |
135,405
+4,532
| +3% | +$235K | 1.13% | 9 |
|
|
2021
Q4 | $7.73M | Buy |
130,873
+7,954
| +6% | +$470K | 1.24% | 11 |
|
|
2021
Q3 | $5.29M | Buy |
122,919
+4,385
| +4% | +$189K | 0.93% | 21 |
|
|
2021
Q2 | $4.64M | Sell |
118,534
-3,412
| -3% | -$134K | 0.81% | 25 |
|
|
2021
Q1 | $4.42M | Buy |
121,946
+34,096
| +39% | +$1.24M | 0.84% | 23 |
|
|
2020
Q4 | $3.23M | Sell |
87,850
-12,195
| -12% | -$449K | 0.68% | 35 |
|
|
2020
Q3 | $3.48M | Buy |
100,045
+11,887
| +13% | +$414K | 0.84% | 26 |
|
|
2020
Q2 | $2.74M | Buy |
88,158
+1,839
| +2% | +$57.1K | 0.73% | 31 |
|
|
2020
Q1 | $2.67M | Sell |
86,319
-1,217
| -1% | -$37.7K | 0.92% | 24 |
|
|
2019
Q4 | $3.25M | Buy |
87,536
+4,678
| +6% | +$174K | 0.84% | 28 |
|
|
2019
Q3 | $2.83M | Sell |
82,858
-1,660
| -2% | -$56.6K | 0.82% | 30 |
|
|
2019
Q2 | $3.47M | Buy |
84,518
+1,156
| +1% | +$47.5K | 1.02% | 21 |
|
|
2019
Q1 | $3.36M | Sell |
83,362
-1,998
| -2% | -$80.5K | 1.01% | 20 |
|
|
2018
Q4 | $3.54M | Buy |
85,360
+78
| +0.1% | +$3.23K | 1.23% | 16 |
|
|
2018
Q3 | $3.57M | Buy |
85,282
+487
| +0.6% | +$20.4K | 1.13% | 16 |
|
|
2018
Q2 | $2.92M | Buy |
+84,795
| New | +$2.92M | 0.96% | 20 |
|